Soleno TherapeuticsSLNO

那斯達克 · USD
0
0
(0%)
收盤 01/01 08:00 (UTC+8)
01/01 08:00 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • 0.33
  • 0.66
  • 0.92
  • 0.95
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • 102.16
  • 38.95
  • 3.13
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
營業收入淨額
94,603
91,730
66,018
32,657
-
-
-
-
-
-
營業成本
1,1988631,141696------
營業毛利
93,405
90,867
64,877
31,961
-
-
-
-
-
-
營業費用
62,12751,29042,77238,48645,74359,11680,212--13,910
研發費用
11,2749,5588,4059,14713,51721,48630,13812,34214,6028,689
推銷及管理費用
50,85341,73234,36729,33932,22637,63050,07412,5268,8735,221
非經常性項目費用
----------
其他營業費用
----------
營業利益
31,278
39,577
22,105
-6,525
-45,743
-59,116
-80,212
-24,868
-23,475
-13,910
其他收入及費用
4,9275,1305,2983,1933,3313,3653,5963,0142,0772,614
利息費用
1,2921,3491,3901,3761,361231----
稅前純益
34,913
43,358
26,013
-4,708
-43,773
-55,982
-76,616
-21,854
-21,398
-11,296
所得稅
3,535---------
稅後純益
31,378
43,358
26,013
-4,708
-43,773
-55,982
-76,616
-21,854
-21,398
-11,296
基本每股稅後盈餘(元)
0.600.820.49-0.09-0.95-1.27-1.83-0.57-0.59-
稀釋每股稅後盈餘(元)
0.590.840.55-0.05-0.95-1.30-1.92-0.57-0.590.29
基本平均股數(千股)
52091.0053175.0053328.0050483.0046178.0043924.0041879.0038631.0036208.00-
稀釋平均股數(千股)
53066.0054331.0054921.0050483.0046178.0043924.0041879.0038631.0036208.00-
還原基本每股稅後盈餘(元)
0.600.820.49-0.09-0.95-1.27-1.83-0.57-0.59-
還原稀釋每股稅後盈餘(元)
0.590.840.55-0.05-0.95-1.30-1.92-0.57-0.590.29
還原基本平均股數(千股)
52,09153,17553,32850,48346,17843,92441,87938,63136,208-
還原稀釋平均股數(千股)
53,06654,33154,92150,48346,17843,92441,87938,63136,208-
EBITDA(千元)
36,50644,03327,543-3,795-42,880-56,648-78,025-22,473-21,381-10,807

大家都在看

HOT